Trial NCT02547220

View at ClinicalTrials.gov 
Org. Study IDs: SHP616-302
Secondary IDs: 2015-000726-11

Last trial update was posted on 2020-07-13

MeSH Interventions

Complement C1 Inhibitor Protein

MeSH Conditions


Other Conditions

Acute Antibody-Mediated Rejection (AMR)

Stopping Reasons

Following a pre-scheduled interim analysis performed by the DMC, it was determined that the study met the pre-specified criteria for futility.

Limitations And Caveats

This study was prematurely terminated at Month 36 due to futility issue.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID